Internal Medicine Doctors in Madill, OK Accepting Medicare
2 Internal Medicine doctors found. Showing 1 - 2
 Dr. Ely R Gordon, DO, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Brookside Drive, Po Box 847, Madill, OK 73446 Phone: 580-795-5506 Fax: 580-795-5145 |
Joe L Potter, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3 Hospital Drive, Madill, OK 73446 Phone: 580-795-5506 Fax: 580-795-5145 |
News Archive
ASCEND program helps achieve rapid improvements in supply chain performance
Hospitals and health systems participating in the Premier healthcare alliance's ASCEND (Accelerated Supply Chain Endeavor) program have reduced their supply expenses in recently launched categories by up to 24 percent since May 2009.
Rice-led research shows how migratory cancer cells acquire 'stem-like' properties
In the first study of its kind, Rice University researchers have mapped how information flows through the genetic circuits that cause cancer cells to become metastatic. The research reveals a common pattern in the decision-making that allows cancer cells to both migrate and form new tumors. Researchers say the commonality may open the door to new drugs that interfere with the genetic switches that cancer must flip to form both cancer stem cells and circulating tumor cells - two of the main players in cancer metastasis.
Obese patients face lower risk of sudden cardiac death compared to non-obese patients
Obesity has long been identified as a risk factor for cardiovascular disease and heart failure. But, a new study conducted by researchers at the University of Rochester Medical Center found that being skinny confers no advantage when it comes to the risk of dying suddenly from cardiac causes.
Molecular mechanisms regulating tumour initiation in skin SCC uncovered
Advanced online publication in Nature: Researchers at the Université libre de Bruxelles, ULB uncover the molecular mechanisms regulating tumour initiation and cancer stem cells functions in skin squamous cell carcinoma.
QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients
QIAGEN announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer.
› Verified 5 days ago